Strategy of Therapy in Renal Carcinoma — Round Table Report

  • J. P. Blandy
  • F. Edsmyr
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)


Schmidt began with a comprehensive review of the state of the art, drawing attention to some of the more notable gaps in our contemporary approach to renal cell cancer.


Renal Cell Carcinoma Partial Nephrectomy Renal Cell Cancer Renal Carcinoma Advanced Renal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A. Sigel, S. Chlepas, P. Hermanek and A. Herrlinger, Stagnation in der Therapie der Nierentumoren — Chancen einer Besserung, in: “Diagnostik und Therapie das Nierenkarzinomas. Klinische und Experimentelle Urologie (Band 2), E. Schmiedt und H. W. Bauer, eds., W. Zuckschwerdt, Munich (1981)Google Scholar
  2. 2.
    H. Tykkä, K.J. Oravisto, T. Lehtonen, S. Sarna and T. Tallberg, Active specific immunotherapy of advanced renal cell carcinoma, Eur. Urol. 4:250–258 (1978).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • J. P. Blandy
    • 1
  • F. Edsmyr
    • 2
  1. 1.The London HospitalLondonUK
  2. 2.Karolinska HospitalStockholmSweden

Personalised recommendations